Literature DB >> 9711903

Neuropeptide Y and limbic seizures.

S C Baraban1.   

Abstract

Since its discovery in 1982, neuropeptide Y (NPY), a 36 amino-acid member of the pancreatic polypeptide family, has received considerable attention in the field of neuroscience. Originally isolated from porcine brain /86/, NPY is one of the most abundant and widely distributed peptides in the central nervous system. In the brain, NPY is present in the hypothalamus, limbic structures, cerebral cortex, brainstem and striatum /2,71/. Because of the widespread distribution of NPY, it has been implicated in the modulation of a variety of behaviors, including, but not limited to, circadian rhythms /1/, memory retention /33/, feeding /19,56/, sympathetic control of cardiovascular function /89/ and anxiety /42,43/. These functions have been reviewed elsewhere and will not be discussed in great detail here. The present review is intended to provide an overview of recent work implicating a role for NPY in limbic seizures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9711903     DOI: 10.1515/revneuro.1998.9.2.117

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  10 in total

Review 1.  Osteoblastic Actions of the Neuropeptide Y System to Regulate Bone and Energy Homeostasis.

Authors:  Harry Horsnell; Paul A Baldock
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

Review 2.  Bone, brain & beyond.

Authors:  Alexandre Chamouni; Christiane Schreiweis; Franck Oury
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

Review 3.  The NPY system and its neural and neuroendocrine regulation of bone.

Authors:  Ee Cheng Khor; Paul Baldock
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

4.  Interneuron progenitors attenuate the power of acute focal ictal discharges.

Authors:  Estanislao De la Cruz; Mingrui Zhao; Lihua Guo; Hongtao Ma; Stewart A Anderson; Theodore H Schwartz
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

5.  Rapamycin has age-, treatment paradigm-, and model-specific anticonvulsant effects and modulates neuropeptide Y expression in rats.

Authors:  Tamar Chachua; Ka-Lai Poon; Mi-Sun Yum; Leigh Nesheiwat; Kara DeSantis; Jana Velíšková; Libor Velíšek
Journal:  Epilepsia       Date:  2012-09-27       Impact factor: 5.864

Review 6.  Application of Medial Ganglionic Eminence Cell Transplantation in Diseases Associated With Interneuron Disorders.

Authors:  Danping Li; Qiongfang Wu; Xiaohua Han
Journal:  Front Cell Neurosci       Date:  2022-07-05       Impact factor: 6.147

7.  Knowledge, perceptions, and attitudes of students of health-related science colleges towards epilepsy in Taif, Saudi Arabia.

Authors:  Ahmed Mohamed Kabel; Shumukh Abdullah Algethami; Bayan Saaed Algethami; Abeer Saleh Alzahrani; Samiah Khalif Almutairi; Ashwaq Shaman Almutairi
Journal:  J Family Med Prim Care       Date:  2020-05-31

8.  NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice.

Authors:  Yan-Chuan Shi; Shu Lin; Iris P L Wong; Paul A Baldock; Aygul Aljanova; Ronaldo F Enriquez; Lesley Castillo; Natalie F Mitchell; Ji-Ming Ye; Lei Zhang; Laurence Macia; Ernie Yulyaningsih; Amy D Nguyen; Sabrina J Riepler; Herbert Herzog; Amanda Sainsbury
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

Review 9.  Effects of Neuropeptide Y on Stem Cells and Their Potential Applications in Disease Therapy.

Authors:  Song Peng; You-Li Zhou; Zhi-Yuan Song; Shu Lin
Journal:  Stem Cells Int       Date:  2017-10-03       Impact factor: 5.443

10.  Neuropeptide Y upregulates Runx2 and osterix and enhances osteogenesis in mouse MC3T3‑E1 cells via an autocrine mechanism.

Authors:  Bo Zhang; Xiaolei Zhang; Juan Xiao; Xuguang Zhou; Yuan Chen; Chunzheng Gao
Journal:  Mol Med Rep       Date:  2020-09-14       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.